AI-ECG Risk Stratification for Atrial Fibrillation
Background Artificial intelligence–enabled electrocardiography (AI-ECG) has emerged as a potential method for identifying atrial fibrillation (AF) from sinus rhythm. However, its clinical utility and interpretability in routine practice remain uncertain. Objectives The objective of the study was to assess the performance and explainability of an AI-integrated ECG system for AF risk stratification in a multicenter real-world cohort. Methods We enrolled 665 patients aged ≥40 years who underwent 12-lead ECGs using an AI-enabled electrocardiograph (FCP-9900). The device automatically assigned AF risk into 4 categories (low, mid-low, mid-high, and high). Machine-learning models—support vector machine, adaptive boosting, and artificial neural networks—were developed using clinical and ECG-derived variables. Internal validation used stratified 10-fold cross-validation, and external validation used an independent cohort. Feature contributions were assessed with SHapley Additive exPlanations. Results AF prevalence increased across AI-ECG risk categories, with significantly higher odds in the mid-high and high groups vs low. Model 2, which incorporated CHADS2 and CHA2DS2-VASc scores, achieved strong discrimination in internal and external validation (support vector machine AUC 1.00; adaptive boosting 0.97-0.98; artificial neural network 0.89-0.95), outperforming AI-ECG alone (area under the receiver operating characteristic curve: 0.64-0.69). SHapley Additive exPlanations analysis showed CHA2DS2-VASc as the most influential predictor, whereas AI-ECG provided modest incremental value. Conclusions AI-ECG provides rapid, low-cost AF risk estimation from a single sinus rhythm ECG; however, its predictive performance is modest compared with clinical scores. At present, AI-ECG may complement, but not replace, traditional risk stratification.